The primary hyperoxaluria treatment market is driven by the increasing prevalence of PH, advances in medical technology, and growing awareness about the disorder among healthcare professionals and patients. However, the market is hindered by the high cost of treatment, limited availability of effective therapies, and the complex nature of the disorder. Primary hyperoxaluria (PH) is a rare...